Effectiveness of sotalol treatment in symptomatic Brugada syndrome

Kathryn A. Glatter, Qing Wang, Mark Keating, Shenghan Chen, Nipavan Chiamvimonvat, Melvin M. Scheinman

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


We describe a 53-year-old man with recurrent syncopal events and a malignant family history who was treated for 13 years with sotalol drug therapy with no further occurrence of Brugada syndrome symptoms. Genetic testing revealed that he carried a Brugada syndrome sodium channel SCN5A mutation (4189delT). This finding suggests that sotalol may be of therapeutic benefit in such patients.

Original languageEnglish (US)
Pages (from-to)1320-1322
Number of pages3
JournalAmerican Journal of Cardiology
Issue number10
StatePublished - May 15 2004

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Effectiveness of sotalol treatment in symptomatic Brugada syndrome'. Together they form a unique fingerprint.

Cite this